(MENAFN- GlobeNewsWire - Nasdaq) Increasing incidence of chronic diseases, advancements in healthcare IT, and focus on personalized medicine are the major factors which drive the global market growth.Wilmington, Delaware, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, " Clinical Decision Support platform Market by Component (Software and Services), Delivery Mode (On-Premises and Cloud Based), Application (Drug Allergy Alerts, Clinical Guidelines, Drug-Drug Interactions, Clinical Reminders and Others), and End User (Hospitals, Clinics, Ambulatory Care Centers and Academic and Research Institutes): Global Opportunity Analysis and Industry Forecast, 2024-2033" . According to the report, the clinical decision support platform market was valued at $1.2 billion in 2023, and is estimated to reach $2.4 billion by 2033, growing at a CAGR of 7.3% from 2024 to 2033.
Request Sample of the Report on Clinical Decision Support Platform Market 2033 -
Prime determinants of growth
Increasing prevalence of chronic diseases and focus on personalized medicine are the major factors that drive the growth of the clinical decision support platform market. However, high cost of implication hinders market growth. Moreover, rise in adoption of telemedicine offers remunerative opportunities for the expansion of the global clinical decision support platform market.
Report coverage & details
| Report Coverage | Details |
| Forecast Period | 2024–2033 |
| Base Year | 2023 |
| Market Size in 2023 | $1.2 billion |
| Market Size in 2033 | $2.4 billion |
| CAGR | 7.3% |
| No. of Pages in Report | 216 |
| Segments Covered | Component, Delivery mode, Application, End user and Region. |
| Drivers | Increasing Incidence of Chronic Diseases Advancements in Healthcare IT Focus on Personalized Medicine |
| Opportunities | Expansion of Telemedicine |
| Restraints | High Implementation Costs |
Want to Explore More, Connect to our Analyst -
Segment Highlights
Software component is widely used in clinical decision support
The software component of the clinical decision support platform is widely used to enhance decision-making processes in healthcare. It integrates patient data, evidence-based guidelines, and clinical knowledge to provide real-time support to clinicians, improving diagnostic accuracy, treatment planning, and patient outcomes. Its use spans across various medical settings, including hospitals, clinics, and research institutions.
Application of on premise clinical decision support platform
On-premise clinical decision support platforms are preferred for their enhanced data security and control. Healthcare organizations value the ability to manage sensitive patient information within their own infrastructure, ensuring compliance with strict regulatory standards and reducing the risk of data breaches associated with cloud-based solutions.
Drug-drug interaction application of clinical decision support platform's
The clinical decision support platform's drug-drug interaction application helps healthcare providers identify and manage potential adverse interactions between prescribed medications. By analyzing patient medication profiles and referencing comprehensive drug databases, it alerts clinicians to possible contraindications, thus enhancing patient safety, reducing medication errors, and optimizing therapeutic outcomes. This tool is crucial in complex treatment regimens involving multiple medications.
Hospitals are the important end users of clinical decision support platform's
Hospitals are the major end users of clinical decision support platforms, leveraging these systems to improve patient care and operational efficiency. These platforms assist healthcare professionals in making informed clinical decisions, reducing errors, and enhancing treatment outcomes. With extensive patient data and complex care requirements, hospitals benefit significantly from real-time insights and evidence-based recommendations provided by these platforms.
For Purchase Related Queries/Inquiry -
Regional Outlook
The clinical decision support platform market is experiencing significant growth across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominates due to advanced healthcare infrastructure and high adoption rates, while Asia Pacific shows rapid growth driven by increasing healthcare investments and technological advancements.
Key Players
Cerner Corporation Epic Systems Corporation IBM Change Healthcare Medical Information Technology Inc Koninklijke Philips NV Siemens Healthcare Allscripts Healthcare Solutions Inc. Wolters Kluwer NV Mckesson Corporation
The report provides a detailed analysis of these key players in the global clinical decision support platform market. These players have adopted different strategies such as, product launch, expansion, partnership, collaboration and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
Get Customized Reports with your Requirements -
Recent Developments in Clinical Decision Support Platform Market Worldwide
In February 2024, Elsevier Health, a global leader in medical information and data analytics, launched ClinicalKey AI, the first and most advanced clinical decision support tool to be introduced in the US that combines the latest and most trusted medical content with generative artificial intelligence (AI) to help clinicians at the point of care. In February 2023, The province of Nova Scotia, in collaboration with Nova Scotia Health Authority (NSHA) and IWK Health (IWK), announced, a new 10-year agreement has been signed with Oracle Cerner to implement an integrated electronic care record across the province for the more than one million Nova Scotians.
Trending Reports in Healthcare Industry:
Medical Device Outsourcing Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
Sleep Aids Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
Structural Heart Devices Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
Pulse Oximeters Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link:
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences , Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
...
Web:
Follow Us on: LinkedIn Twitter
MENAFN30092024004107003653ID1108732220
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.